🚀 This achievement strengthens the integration of nanotechnology, drug development and biological validation within the IN-ARMOR pipeline, supporting the progression of selected candidates towards preclinical evaluation.
@in-armor.bsky.social
@in-armor.bsky.social🚀 This achievement strengthens the integration of nanotechnology, drug development and biological validation within the IN-ARMOR pipeline, supporting the progression of selected candidates towards preclinical evaluation.
@in-armor.bsky.social🧬 Why is this a major step?
By reinforcing the host’s innate immune system rather than directly targeting bacteria, we aim to tackle antimicrobial resistance (#AMR) without contributing to drug resistance.
Discover more 🌐 inarmor-project.eu
@in-armor.bsky.socialNew milestone achieved!
The consortium has completed the advanced characterisation of its selected lead compounds for host-directed therapies (HDTs) against antimicrobial resistance.
#EUFunded #HaDEA #INARMOR #HorizonEurope #HostDirectedTherapy
